FI973244A0 - Farmaceutiska preparat för intranasal användning Farmaceutiska preparat för intranasal användning - Google Patents
Farmaceutiska preparat för intranasal användning Farmaceutiska preparat för intranasal användningInfo
- Publication number
- FI973244A0 FI973244A0 FI973244A FI973244A FI973244A0 FI 973244 A0 FI973244 A0 FI 973244A0 FI 973244 A FI973244 A FI 973244A FI 973244 A FI973244 A FI 973244A FI 973244 A0 FI973244 A0 FI 973244A0
- Authority
- FI
- Finland
- Prior art keywords
- pharmaceutical preparations
- intranasal use
- intranasal
- preparations
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Otolaryngology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8282866A JP3020141B2 (ja) | 1996-10-07 | 1996-10-07 | 経鼻投与用製剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
FI973244A0 true FI973244A0 (sv) | 1997-08-06 |
FI973244A FI973244A (sv) | 1998-04-08 |
Family
ID=17658107
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI973244A FI973244A (sv) | 1996-10-07 | 1997-08-06 | Farmaceutiska preparat för intranasal användning |
Country Status (16)
Country | Link |
---|---|
US (1) | US5948749A (sv) |
JP (1) | JP3020141B2 (sv) |
KR (1) | KR19980032364A (sv) |
CN (1) | CN1180569A (sv) |
AU (1) | AU3992697A (sv) |
CA (1) | CA2217409A1 (sv) |
DE (1) | DE19740733A1 (sv) |
DK (1) | DK114797A (sv) |
ES (1) | ES2126536B1 (sv) |
FI (1) | FI973244A (sv) |
FR (1) | FR2754453A1 (sv) |
GB (1) | GB2322077A (sv) |
GR (1) | GR970100333A (sv) |
IT (1) | IT1295047B1 (sv) |
NO (1) | NO974618L (sv) |
SE (1) | SE9703133L (sv) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7022683B1 (en) | 1998-05-13 | 2006-04-04 | Carrington Laboratories, Inc. | Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation |
CA2341732C (en) * | 1998-08-26 | 2008-08-19 | Teijin Limited | Powder composition for nasal administration |
US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
DE60031133T2 (de) * | 1999-06-30 | 2007-04-12 | Takeda Pharmaceutical Co. Ltd. | Verfahren zur darstellung von lh-rh-derivaten |
US6382204B1 (en) | 1999-10-14 | 2002-05-07 | Becton Dickinson And Company | Drug delivery system including holder and drug container |
US6777000B2 (en) | 2001-02-28 | 2004-08-17 | Carrington Laboratories, Inc. | In-situ gel formation of pectin |
US20040126900A1 (en) * | 2001-04-13 | 2004-07-01 | Barry Stephen E | High affinity peptide- containing nanoparticles |
PT1494732E (pt) | 2002-03-20 | 2008-03-20 | Mannkind Corp | Aparelho de inalação |
US20080260838A1 (en) * | 2003-08-01 | 2008-10-23 | Mannkind Corporation | Glucagon-like peptide 1 (glp-1) pharmaceutical formulations |
WO2004073729A1 (ja) * | 2003-02-21 | 2004-09-02 | Translational Research Ltd. | 薬物の経鼻投与用組成物 |
WO2004084859A2 (en) * | 2003-03-21 | 2004-10-07 | Nastech Pharmaceutical Company Inc. | Nasal calcitonin formulations containing chlorobutanol |
CA2519287A1 (en) | 2003-03-27 | 2004-10-14 | Bioactis Limited | Powder medicine applicator for nasal cavity |
JP4922762B2 (ja) * | 2004-08-10 | 2012-04-25 | 株式会社新日本科学 | 速効性でかつ高い吸収性を可能とする経鼻投与用組成物 |
BRPI0514263B8 (pt) | 2004-08-20 | 2021-05-25 | Mannkind Corp | método para a síntese de bis-3,6-[4-aminobutil]-2,5-dicetopiperazina n-protegida |
CA2578175C (en) | 2004-08-23 | 2014-10-14 | Mannkind Corporation | Diketopiperazine salts, diketomorpholine salts or diketodioxane salts for drug delivery |
US7115561B2 (en) * | 2004-09-22 | 2006-10-03 | Patterson James A | Medicament composition and method of administration |
FR2880272A1 (fr) * | 2005-01-04 | 2006-07-07 | Jean Marc Ruiz | Preparation contenant des microparticules d'un sel de polymere insoluble portant un principe actif, ainsi que son procede de fabrication |
EP1937219B1 (en) | 2005-09-14 | 2015-11-11 | MannKind Corporation | Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents |
IN2015DN00888A (sv) | 2006-02-22 | 2015-07-10 | Mannkind Corp | |
WO2008005577A2 (en) * | 2006-07-07 | 2008-01-10 | University Of South Florida | Compositions of polyphenols and methods of use |
ES2652415T3 (es) | 2006-12-26 | 2018-02-02 | Shin Nippon Biomedical Laboratories, Ltd. | Preparación para aplicación transnasal |
BRPI0818872A2 (pt) * | 2007-10-24 | 2015-05-05 | Mannkind Corp | Método para prevenir efeitos adversos por glp-1 |
WO2011163272A1 (en) | 2010-06-21 | 2011-12-29 | Mannkind Corporation | Dry powder drug delivery system and methods |
PL2293833T3 (pl) | 2008-06-13 | 2016-08-31 | Mannkind Corp | Inhalator proszkowy i układ do dostarczania leku |
US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
DK2609954T3 (da) | 2008-06-20 | 2022-02-14 | Mannkind Corp | Interaktivt apparat til realtidsafbildning af inhalationspræstationer |
TWI532497B (zh) | 2008-08-11 | 2016-05-11 | 曼凱公司 | 超快起作用胰島素之用途 |
US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
PL2405963T3 (pl) | 2009-03-11 | 2014-04-30 | Mannkind Corp | Urządzenie, układ i sposób pomiaru oporu inhalatora |
US9101539B2 (en) * | 2009-05-15 | 2015-08-11 | Shin Nippon Biomedical Laboratories, Ltd. | Intranasal pharmaceutical compositions with improved pharmacokinetics |
KR102584844B1 (ko) | 2009-06-12 | 2023-10-04 | 맨카인드 코포레이션 | 한정된 비표면적을 갖는 디케토피페라진 마이크로입자 |
WO2011013003A2 (en) * | 2009-07-31 | 2011-02-03 | Shin Nippon Biomedical Laboratories, Ltd. | Intranasal granisetron and nasal applicator |
JP5784622B2 (ja) | 2009-11-03 | 2015-09-24 | マンカインド コーポレ−ション | 吸入活動をシミュレートするための装置及び方法 |
SG10201606220QA (en) | 2011-04-01 | 2016-09-29 | Mannkind Corp | Blister package for pharmaceutical cartridges |
WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
US9233159B2 (en) | 2011-10-24 | 2016-01-12 | Mannkind Corporation | Methods and compositions for treating pain |
CN104619369B (zh) | 2012-07-12 | 2018-01-30 | 曼金德公司 | 干粉药物输送系统和方法 |
US10159644B2 (en) | 2012-10-26 | 2018-12-25 | Mannkind Corporation | Inhalable vaccine compositions and methods |
BR112015023168B1 (pt) | 2013-03-15 | 2021-08-10 | Mannkind Corporation | Composição de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina cristalina, método de produção de partículas de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina e uso de uma composição de dicetopiperazina cristalina |
CA2918369C (en) | 2013-07-18 | 2021-06-29 | Mannkind Corporation | Heat-stable dry powder pharmaceutical compositions and methods |
US11446127B2 (en) | 2013-08-05 | 2022-09-20 | Mannkind Corporation | Insufflation apparatus and methods |
CN103638527A (zh) * | 2013-12-05 | 2014-03-19 | 浙江大学 | 促红细胞生成素载药纳米粒及其应用 |
US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
MX2017005692A (es) | 2014-10-31 | 2017-08-07 | Glaxosmithkline Ip Dev Ltd | Formulacion en polvo. |
CN106362158A (zh) * | 2015-07-25 | 2017-02-01 | 于杰 | 增效药物 |
US11744967B2 (en) | 2017-09-26 | 2023-09-05 | Shin Nippon Biomedical Laboratories, Ltd. | Intranasal delivery devices |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB792544A (en) * | 1956-05-07 | 1958-03-26 | American Home Prod | Therapeutic composition |
JPS4917563B1 (sv) * | 1970-12-28 | 1974-05-01 | ||
GB2042888B (en) * | 1979-03-05 | 1983-09-28 | Teijin Ltd | Preparation for administration to the mucosa of the oral or nasal cavity |
JPS59163313A (ja) * | 1983-03-09 | 1984-09-14 | Teijin Ltd | 経鼻投与用ペプチドホルモン類組成物 |
JPS62223131A (ja) * | 1986-03-26 | 1987-10-01 | Nitto Electric Ind Co Ltd | 持続性鼻疾患治療剤 |
US5112804A (en) * | 1987-04-01 | 1992-05-12 | Temple University Of The Commonwealth System Of Higher Education | Pharmaceutical composition and method of intranasal administration |
GB8723846D0 (en) * | 1987-10-10 | 1987-11-11 | Danbiosyst Ltd | Bioadhesive microsphere drug delivery system |
US5554388A (en) * | 1989-02-25 | 1996-09-10 | Danbiosyst Uk Limited | Systemic drug delivery compositions comprising a polycationi substance |
GB8904370D0 (en) * | 1989-02-25 | 1989-04-12 | Cosmas Damian Ltd | Liquid delivery compositions |
US5342922A (en) * | 1989-03-08 | 1994-08-30 | Washington University | Inhibitors of retroviral protease |
US5158761A (en) * | 1989-04-05 | 1992-10-27 | Toko Yakuhin Kogyo Kabushiki Kaisha | Spray gel base and spray gel preparation using thereof |
US5397771A (en) * | 1990-05-10 | 1995-03-14 | Bechgaard International Research And Development A/S | Pharmaceutical preparation |
GB9203769D0 (en) * | 1992-02-21 | 1992-04-08 | Sandoz Ltd | Improvements in or relating to organic compounds |
ES2159524T3 (es) * | 1992-06-12 | 2001-10-16 | Teijin Ltd | Preparacion farmaceutica para administrarse en el interior de las vias respiratorias. |
WO1994005619A1 (en) * | 1992-09-10 | 1994-03-17 | Teijin Limited | 4-hydroxy-2-cyclopentenone derivative and carcinostatic and osteogenesis promoter containing the same |
DK0619305T3 (da) * | 1993-02-05 | 1997-07-07 | Teijin Ltd | Lactonforbindelse og fremgangsmåde til fremstilling deraf |
JP3098401B2 (ja) * | 1995-07-12 | 2000-10-16 | 株式会社エルティーティー研究所 | 経鼻投与用製剤 |
-
1996
- 1996-10-07 JP JP8282866A patent/JP3020141B2/ja not_active Expired - Fee Related
-
1997
- 1997-08-06 FI FI973244A patent/FI973244A/sv unknown
- 1997-08-27 GR GR970100333A patent/GR970100333A/el unknown
- 1997-08-29 SE SE9703133A patent/SE9703133L/sv not_active Application Discontinuation
- 1997-09-03 US US08/922,775 patent/US5948749A/en not_active Expired - Fee Related
- 1997-09-04 KR KR1019970045853A patent/KR19980032364A/ko not_active Application Discontinuation
- 1997-09-04 GB GB9718690A patent/GB2322077A/en not_active Withdrawn
- 1997-09-05 ES ES09701891A patent/ES2126536B1/es not_active Expired - Lifetime
- 1997-09-16 DE DE19740733A patent/DE19740733A1/de not_active Withdrawn
- 1997-09-22 IT IT97MI002144A patent/IT1295047B1/it active IP Right Grant
- 1997-10-03 FR FR9712321A patent/FR2754453A1/fr active Pending
- 1997-10-03 AU AU39926/97A patent/AU3992697A/en not_active Abandoned
- 1997-10-06 CN CN97120047A patent/CN1180569A/zh active Pending
- 1997-10-06 NO NO974618A patent/NO974618L/no unknown
- 1997-10-06 CA CA002217409A patent/CA2217409A1/en not_active Abandoned
- 1997-10-07 DK DK114797A patent/DK114797A/da not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DE19740733A1 (de) | 1998-04-09 |
GR970100333A (el) | 1998-06-30 |
ITMI972144A1 (it) | 1999-03-22 |
ES2126536B1 (es) | 1999-10-01 |
JP3020141B2 (ja) | 2000-03-15 |
IT1295047B1 (it) | 1999-04-27 |
FI973244A (sv) | 1998-04-08 |
GB2322077A (en) | 1998-08-19 |
JPH10114645A (ja) | 1998-05-06 |
AU3992697A (en) | 1998-04-09 |
ES2126536A1 (es) | 1999-03-16 |
DK114797A (da) | 1998-04-08 |
FR2754453A1 (fr) | 1998-04-17 |
US5948749A (en) | 1999-09-07 |
GB9718690D0 (en) | 1997-11-12 |
KR19980032364A (ko) | 1998-07-25 |
CN1180569A (zh) | 1998-05-06 |
NO974618D0 (no) | 1997-10-06 |
NO974618L (no) | 1998-04-08 |
CA2217409A1 (en) | 1998-04-07 |
SE9703133D0 (sv) | 1997-08-29 |
SE9703133L (sv) | 1998-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI973244A0 (sv) | Farmaceutiska preparat för intranasal användning Farmaceutiska preparat för intranasal användning | |
DK0921796T3 (da) | Tetrahydrolipstatinholdige præparater | |
DE69828330D1 (de) | Aktiviertes Protein C Formulierungen | |
IS5953A (is) | Lyfjablöndur úr örgerðum eplerenonum | |
NO986208L (no) | Vandige peptidformuleringer | |
NO995712D0 (no) | Oftalmiske preparater | |
IS6040A (is) | Valdekoxib efnablöndur | |
DE69722620D1 (de) | Nicht-waessrige protische peptidzubereitungen | |
FI962231A0 (fi) | Traeskelarrangemang hos en hisskorg | |
DE59710000D1 (de) | Fördervorrichtung | |
NO985539D0 (no) | Farmas°ytiske blandinger | |
DE59707298D1 (de) | Desodorierende zubereitungen | |
ATE196152T1 (de) | Peptidderivate | |
DE59704688D1 (de) | Fördereinrichtung | |
DE69926012D1 (de) | Arzneizubereitungen | |
DK1041966T3 (da) | Farmaceutiske præparater omfattende zafirlukast | |
NO980058D0 (no) | Opthalmiske preparater | |
ATE246494T1 (de) | Brausezubereitungen | |
DE69906934D1 (de) | Arzneizubereitungen | |
TR199701666A3 (tr) | Sismanliga karsi proteinler | |
DE69806425D1 (de) | Schlauchanordnungen | |
DE69724955D1 (de) | Bandförderer | |
DE69811604D1 (de) | Förderanlage | |
FI974610A0 (fi) | Farmaceutiskt preparat i gelform | |
DE50009295D1 (de) | Vernetzerfreie zubereitungen |